Sensus Blog

The future of skin cancer treatment is now. Stay ahead of the curve with our library of informational blogs.

April
27
2026

Basal Cell Carcinoma vs. Squamous Cell Carcinoma: What’s the Difference?

Melanoma and non-melanoma are two primary categories of skin cancer. Each presents different symptoms and treatment options. Within the non-melanoma skin cancer – sometimes referred to as NMSC – category, the two most common types…

January
06
2020

Sensus Healthcare Announces Management Promotions

New corporate structure positions company for 2020 financial goals BOCA RATON, Fla., Jan. 06, 2020 — Sensus Healthcare, Inc. (Nasdaq: SRTS), a medical device company specializing in highly effective, non-invasive, minimally-invasive and cost-effective treatments for…

January
03
2020

85.6% Cure Rate for Keloids Treated by SRT Post Surgery

Those who suffer from keloid scarring are often left wondering what they can do to finally get rid of their keloids for good. Superficial Radio Therapy is quickly becoming a popular solution to treat keloids…

December
27
2019

Battling Skin Cancer? Look No Further than the Non-Surgical SRT-100™ for Your Squamous Cell Carcinoma Treatment

Squamous cell carcinoma is the second most common type of skin cancer. There are more than 700,000 new cases diagnosed each year in the United States. Fortunately, there is a new Squamous Cell Carcinoma Treatment…

December
18
2019

SRT-100™: Cure Your Patients with This Revolutionary Non-Surgical Squamous Cell Carcinoma Treatment

Each year, there are more new cases of skin cancer than the combined incidence of cancers of the breast, prostate and colon. Nearly four million people in the United States will be diagnosed with basal…

Archives
Archives

IN THE NEWS

CEO Joseph Sardano on Coding for Superficial Radiation Therapy